An analysis shows that 27% fewer drugs launched in Europe since President Trump’s international drug-pricing policy began.
Trump’s Plan to Lower Drug Prices in U.S. Is Leading to Fewer New Drugs in Europe
Discover more from UM LEGACY PRESS LTD
Subscribe to get the latest posts sent to your email.